SDGR
Schrödinger develops physics-based chemical simulation software used to accelerate discovery in drug development, biotechnology, and materials science. Its computational platform enables molecular modeling, structure prediction, and materials design to support pharmaceutical and industrial research globally. The company emphasizes solutions for life science and materials science applications, with a strong focus on enabling faster, more accurate molecular discovery. Headquartered in the United States with global activities, Schrödinger positions itself as a leader in digital chemistry for therapeutics and materials innovation.
No recent news for this company.
No recent deals for this company.